Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients - 05/09/11
, b, ⁎ 
Abstract |
There are few data comparing the relative frequency of new electrocardiographic (ECG) abnormalities after coronary artery bypass grafting (CABG) compared with percutaneous transluminal coronary angioplasty (PTCA) and their association with long-term cardiac mortality. The study population consisted of 3,373 patients who were either randomized or eligible to be randomized to CABG or PTCA in the BARI trial. The frequency of new postprocedural ECG abnormalities was significantly greater after a CABG procedure than after PTCA. The incidence of new postprocedural major Q waves, ST-segment elevation, and T-wave abnormalities were significantly more frequent after CABG. After PTCA (n = 1,869), the 5-year cardiac mortality rates associated with the new development of major Q waves, ST-segment elevation, ST-segment depression, T-wave abnormalities, or no abnormality was 18.1%, 8.5%, 8.9%, 6.0%, and 5.4%, respectively. After CABG (n = 1,427), 5-year cardiac mortality rates were 8.0%, 4.2%, 3.8%, 2.8%, and 3.7%, respectively. The adjusted relative risk of 5-year cardiac mortality for new Q-wave abnormalities was 2.6 after CABG (p <0.04) and 4.6 after PTCA (p <0.01). Thus, patients who undergo CABG have more postinitial procedural ECG abnormalities than patients who undergo PTCA. Cardiac mortality is significantly increased by the new development of postprocedural Minnesota code Q-wave abnormalities regardless of whether patients undergo CABG or PTCA.
Le texte complet de cet article est disponible en PDF.Plan
 | The Bypass Angioplasty Revascularization Investigation is supported by Grants HL38493, HL38504, HL38509, HL38512, HL38514–6, HL38518, HL38524–5, HL38529, HL38532, HL38556, HL38610, HL38642, and HL42145 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. |
Vol 86 - N° 8
P. 819-824 - août 2000 Retour au numéro
Article précédent
- Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction
- Stacy D. Fisher, Wojciech Zareba, Arthur J. Moss, Victor J. Marder, Charles E. Sparks, Judith Hochman, Chang-Seng Liang, Ronald J. Krone, for the THROMBO Investigators∗The THROMBO Investigators are listed in the . ∗ Appendix
- Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease
- Andrew J Burger, Michael P Notarianni, Doron Aronson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?